The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

IBM and Moderna released research on Thursday advancing the use of quantum computing in the development of mRNA medicines, a ...

While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...

A veteran drug development leader, Dr. Ivarsson most recently served as Senior Vice President and Chief Development Officer at Moderna, where she was honored as an Officer of the Order of the ...

IBM is seeking a long-term partnership with Japan's Rapidus to develop sub-1nm chips, according to . Building on their 2nm collaboration, IBM has deployed engineers to Rapidus's Hokkaido site ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.

With pharmaceutical innovation representing one of the bright spots for positive change in health care, appreciating the impact of policy is key to a healthier and more competitive America.

One of the first and most promising uses scientists envision for the rapidly evolving technology of quantum computing is a new approach to drug development. A quantum computer could, in theory ...